This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
Momenta Pharmaceuticals Inc. (MNTA)
Q2 2012 Results Earnings Call
August 2, 2012 10:00 AM ET
Lora Pike – Senior Director, Investor Relations and Corporate Communication
Craig Wheeler – President and CEO
Rick Shea – Chief Financial Officer
Ronny Gal – Bernstein
Sumant Kulkarni – Bank of America
Ritu Baral – Canaccord
Joseph Schwartz – Leerink Swann
Ami Fadia – UBS
Imran Babar – Cowen
Good day, ladies and gentlemen, and thank you for your patience. You’ve joined the Momenta Pharmaceuticals’ Second Quarter 2012 Earnings Call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session, and instructions will be given at that time. As a reminder, this conference maybe recorded.
I would now like to turn the call over to your host, the Senior Director of Investor Relations and Corporate Communication, Ms. Lora Pike. Ma’am, you may begin.
Thanks, Al, and good morning, everyone. We thank you for joining us today for Momenta’s conference call to discuss financial results for the second quarter of 2012. Today’s call is being webcast and you can view the slide that we will be presenting in the Investor section of our website at momentapharma.com.
Joining me on the call with prepared remarks are Craig Wheeler, President and Chief Executive Officer, who will provide an update on our major program, followed by Rick Shea, Chief Financial Officer, who will provide a brief review of our second quarter results.